The main objective of the study is to assess the effect of treprostinil palmitil inhalation powder (TPIP) compared with placebo on pulmonary vascular resistance.
- Investigator
- Ali Ataya
- Status
- Accepting Candidates
- Ages
- 18 Years - 75 Years
- Sexes
- All
Research at a glance
Top areas of exploration
- Dyspnea , 10 publications
- Pulmonary Embolism , 4 publications
- Lung Diseases , 4 publications
- Pleural Effusion , 4 publications
Research activity
Active clinical trials
160 subjects with autoimmune pulmonary alveolar proteinosis (aPAP) will be randomized to receive once daily treatment with inhaled molgramostim or placebo for 48 weeks. Subjects completing the 48 week placebo-controlled period will receive…
- Investigator
- Ali Ataya
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
Study ROR-PH-303, ADVANCE EXTENSION, is an open-label extension (OLE) study for participants with WHO Group 1 PAH who have participated in another Phase 2 or Phase 3 study of ralinepag.
- Investigator
- Ali Ataya
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
My publications
Filter publications
103 publications
2024
Diffuse hyperdense micronodular airspace opacities in pulmonary alveolar microlithiasis
Thorax
Publisher's site2024
Progressive Dyspnea on Exertion in an 82-Year-Old.
JAMA
PubMed • Publisher's site2023
A 28-Year-Old Woman With Nail Discoloration, Recurrent Bronchitis, and Left-Sided Facial Swelling
CHEST
Publisher's site2023
Intralobar pulmonary sequestration presenting as recurrent left lower lobe pneumonia
Baylor University Medical Center Proceedings
PubMed • Publisher's site2023
Managing High Cardiac Output Failure in a Patient With Hereditary Hemorrhagic Telangiectasias During Pregnancy
JACC: Case Reports
PubMed • Publisher's site